Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Made an abortive attempt at writing about religion.
any negatives to speak of?
material news has to be PR’d...BEFORE the CC
FDA rushed so much , when Dr Fauci from the WH asked openly for EUA for this mostly worthless drug Remdesivir , FDA issued EUA 2-3 days later.
because treating them with Lenzulimab will not help them
Its over for CYDY- no approvals, no money without a declaration of effectiveness from the SEC, no successful clinical trials.
since marty put the screws to them
"leronlimab is being used all over the world- the supply is TIGHT"
No reason , except FDA didnt allow them to use 4 weeks of treatment with leronlimab , and 3:1 ratio with over 65 years old ,in the drug arm happened ..
I dont know how this could happen in the study with 2:1 ratio.
You excluded 19 from the active arm and 14 from placebo your trial
Misiu--there must be a LOT of people being told 100,000 doses for HGEN
when it comes to cherry picking you guys wrote the book on that.
That's what happens when every CC only serves as a reminder that absolutely nothing has gotten accomplished. Every single time Nader has had to clarify one of his pump PRs the pump has vanished because they thrive on obscurity. That's why the silly doctors who think they are smart for investing in this junk get fooled so easy. When they come up against obscurity it's like they are toddlers.
And our results in the studies are great.
NP speaks = Cydy SP goes down
Nothing is a secret in treating patients here..
--Patient about 70 days on ECMO , ( England ) , last rights given by a priest ,
leronlimab is injected , and few days later patient is off ECMO , and another few days don't need the oxygen,,
-- former president of Philippines admitted to the hospital March 28 , treated with ALL possible drugs including Remdesivir , and deteriorating .
Placed on the ventilator April 5 , April 8 received first injection of leronlimab , and the next day off the ventilator ..
That will be really great , so if he AIMS for 100,000 doses , they may even have 500,000 , like what they ordering for 5 hospitals in Philippines with Leronlimab
I’d blink once and than go with a far superior therapy drug LERONLIMAB
Not that to treat internationally or in USA 100,000 patients is a big thing.
So this is only in one place printed I saw , they could misunderstood , show me where CEO said this during CC , I made a point to listened to last few ,
never happened , he always said 100,000 doses , but why don't you e-mail you CEO , I am sure he be happy to answer .
https://www.reuters.com/business/healthcare-pharmaceuticals/humanigen-says-drug-improves-ventilator-free-survival-covid-19-patients-2021-03-29/
"We are scaling up our manufacturing and we hope to have enough therapies to be able to treat 100,000 patients over course of the next 12 months," CEO Durrant said.
I heard the HGEN call, and like Misiu, I heard 100,000 doses and it takes 3 doses per patient.
https://www.reuters.com/business/healthcare-pharmaceuticals/humanigen-says-drug-improves-ventilator-free-survival-covid-19-patients-2021-03-29/
"We are scaling up our manufacturing and we hope to have enough therapies to be able to treat 100,000 patients over course of the next 12 months," CEO Durrant said.
IN 12 MONTHS we AIM to have 100,000 doses
https://www.reuters.com/business/healthcare-pharmaceuticals/humanigen-says-drug-improves-ventilator-free-survival-covid-19-patients-2021-03-29/
"We are scaling up our manufacturing and we hope to have enough therapies to be able to treat 100,000 patients over course of the next 12 months," CEO Durrant said.
Oh ok, the shorts...so why isn't ANYONE buying it??!!!! It should be squeezing right now..it's not because... NOBODY is buying it. Nobody is buying it because the market doesn't see it as a good investment.
$10,000 at minimum WOW! Who’s going to pay that ?
I wouldn't be so excited about 5% that stock should be at $30 at least right now. What's wrong with it? Why isn't anyone buying it?
only enough for 30,000 by end of year
HGEN is garbage, day traders pushed it up to $19 it tested it three times, couldn't break through so they dumped. Nobody want that stock.. because nobody wants lenz.. NOBODY. it's sad when it could've even break past $20
It is criminal.
a protection of CYDY good name
Looking like the people have finally figured out that these CCs they keep throwing at us are bad for the SP, so they are getting out in advance instead of the day after
All of Tech is down. HGEN is actually down a lot less than most Covid therapeutic stocks. I bet we end the day green.
Everyone knows the less patients the more difficult to meet anything.
In terms of side effects in CD10 , PR dating April 11, 2020.
Summery of side effects ..
" Patients treated with placebo were more then twice as likely to experience SAEs and AEs compare to patients treated with Leronlimab "
This I never saw in a study that placebo has more side effects than the drug..
Decrease hospitalization from 10.7% to 1.7% , a 63% reduction when compare to placebo.
In terms of toxicity, adverse events (AEs) of any grade were seen in 33 patients (39.3%), while mild events occurred in 17 (20.2%), moderate in 8 (9.5%), and severe in 8 (9.5%). incidence, frequency, and severity of AEs were lower with leronlimab compared with placebo, in which AEs of any grade were observed in 19 patients (33.9%) versus 14 (50.0%), of mild severity in 12 (21.4%) versus 5 (17.9%), moderate in 2 (3.6%) versus 6 (21.4%), and severe in 5 (8.9%) versus 3 (10.7%), respectively. Eight serious AEs occurred in 56 patients (14%) in the leronlimab arm compared with 11 in 28 patients (39%) from the placebo arm.
https://www.targetedonc.com/view/protocol-filed-with-fda-for-phase-2-trial-of-leronlimab-to-treat-long-hauler-symptoms-of-covid-19
That was exactly my point Lenzilumab dont even talk about mortality , and I believe if they could they would,
We SS for Length of Hospitalization for entire trial , and in contrary to lenzilumab with mortality with subgroups.
At this point it is enough of my hard work , and you do your on DD.
In our M/M study ..
Treatment of M/M patients with COVID decreased the incidence of hospitalization by 83% when compare to placebo
I don't lie
we reduced over 80% progression from moderate to severe
We SS for Length of Hospitalization for entire trial
I will love to see to compare against study with lenzilumab for their moderately severe patients study